A detailed history of Cidel Asset Management Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Cidel Asset Management Inc holds 6,981 shares of ABBV stock, worth $1.19 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
6,981
Previous 6,981 -0.0%
Holding current value
$1.19 Million
Previous $1.2 Million 15.12%
% of portfolio
0.11%
Previous 0.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 19, 2024

BUY
$154.79 - $180.76 $57,117 - $66,700
369 Added 5.58%
6,981 $1.2 Million
Q1 2024

May 08, 2024

BUY
$159.82 - $182.1 $18,379 - $20,941
115 Added 1.77%
6,612 $1.2 Million
Q4 2023

Feb 12, 2024

BUY
$137.6 - $154.97 $893,987 - $1.01 Million
6,497 New
6,497 $1.01 Million
Q2 2019

Aug 08, 2019

SELL
$65.7 - $83.98 $169,965 - $217,256
-2,587 Closed
0 $0
Q2 2018

Aug 13, 2018

BUY
$89.78 - $106.23 $232,260 - $274,817
2,587 New
2,587 $240,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $301B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Cidel Asset Management Inc Portfolio

Follow Cidel Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cidel Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cidel Asset Management Inc with notifications on news.